COMMUNIQUÉS West-GlobeNewswire

Sonoma Pharmaceuticals Announces Fiscal Year/Fourth Quarter 2018 Financial Results and Conference Call

31/05/2018 - 13:05

PETALUMA, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA ), today announced that financial results for its fiscal fourth quarter 2018, ended March 31, 2018, will be released after [...]

GeneSight® Guided Treatment Significantly Improves Outcomes for Patients with Major Depression Treated in the Primary Care Setting

31/05/2018 - 13:05

New Results from the IMPACT Study to be Presented at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting SALT LAKE CITY, May 31, 2018 (GLOBE NEWSWIRE) -- Assurex Health, a wholly-owned subsidiary [...]

Nasdaq Approves Listing of IMV Inc. Common Shares

31/05/2018 - 13:05

HALIFAX, Nova Scotia, May 31, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (“IMV” or the “Corporation”) (TSX: IMV ) (OTCQX:IMMVD), a clinical stage immunotherapy company, today announced that its common shares have been approved [...]

APTOSE Enters into US$20 Million Common Share Purchase Agreement with Aspire Capital Fund, LLC

31/05/2018 - 13:04

SAN DIEGO and TORONTO, May 31, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics that target [...]

Innovate Biopharmaceuticals Scheduled to Present at the Jefferies Global Healthcare Conference in New York on Friday, June 8, 2018, at 11:30AM

31/05/2018 - 13:02

RALEIGH, N.C., May 31, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT ), a clinical stage biotechnology company focused on developing novel therapeutics for immuno-inflammatory [...]

ObsEva SA to Participate in Jefferies Global Healthcare Conference June 5-8, 2018

31/05/2018 - 13:01

Geneva, Switzerland and Boston, MA -May 31, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that [...]

Merus to Present at the Jefferies 2018 Healthcare Conference

31/05/2018 - 13:00

UTRECHT, The Netherlands, May 31, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS ), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics ® ), today announced that [...]

Nabriva Therapeutics to Present Lefamulin Data at ASM Microbe

31/05/2018 - 13:00

Potential of Lefamulin to Treat Patients with CABP Against Backdrop of Increasing Bacterial Resistance Presented on Eight Posters DUBLIN, Ireland, May 31, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV [...]

miRagen Therapeutics to Present at Jefferies 2018 Global Healthcare Conference on Thursday, June 7th

31/05/2018 - 13:00

BOULDER, Colo., May 31, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced today [...]

T2 Biosystems Announces Pricing of Public Offering of Common Stock

31/05/2018 - 13:00

LEXINGTON, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ) today announced the pricing of an underwritten registered public offering of 6,100,000 shares of common stock at a public offering [...]

Arcturus Announces Management Appointments; Company Founder Joseph E. Payne Reinstated as President and CEO

31/05/2018 - 13:00

Industry veteran Dr. Peter Farrell named as Chairman of the Board, Dr. Pad Chivukula reinstated as CSO and COO SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA [...]

Axovant to Present at Two Upcoming Investor Conferences

31/05/2018 - 13:00

BASEL, Switzerland, May 31, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ: AXON ) today announced that Pavan Cheruvu, M.D., chief executive officer, will present a corporate overview at the Jefferies 2018 Global [...]

Apellis Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference

31/05/2018 - 13:00

CRESTWOOD, Ky. and CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds [...]

BeyondSpring to Present at Upcoming Conferences

31/05/2018 - 13:00

NEW YORK, May 31, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global, clinical-stage biopharmaceutical company focused on the development of transformative cancer therapies, today announced that [...]

Dova Pharmaceuticals Announces Availability of DOPTELET® in the United States

31/05/2018 - 13:00

DURHAM, N.C., May 31, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today announced the availability of DOPTELET in the United States for the treatment of thrombocytopenia in adult patients with [...]

Scholar Rock Announces Completion of Dosing of First Cohort in Phase 1 Clinical Trial of SRK-015

31/05/2018 - 13:00

CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Scholar Rock (NASDAQ: SRRK ), a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in [...]

Madrigal’s MGL-3196 Achieves Liver Biopsy Endpoints in Patients with Non-alcoholic Steatohepatitis (NASH) at 36 Weeks in Phase 2 Clinical Trial

31/05/2018 - 12:50

-- Statistically significantly more patients treated with MGL-3196 compared with placebo treated patients achieved a two point reduction in NAS (NAFLD activity score) on biopsy -- -- Statistically significantly more [...]

Clementia to Present at the Jefferies 2018 Global Healthcare Conference

31/05/2018 - 12:30

MONTREAL, May 31, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ: CMTA ), a clinical-stage biopharmaceutical company innovating new treatments for people with ultra-rare bone disorders and other [...]

Clementia Annonce qu’elle Participera à la Conférence Annuelle 2018 sur les Soins de Santé Jefferies (« Jefferies 2018 Global Healthcare Conference »)

31/05/2018 - 12:30

MONTRÉAL, 31 mai 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ: CMTA ), une société biopharmaceutique au stade clinique proposant des traitements novateurs pour les personnes atteintes de troubles [...]